Search Results - Danny Khalil

First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments by Aung Naing, Danny Khalil, Matthew Thomas, Tom Lillie, Oliver Rosen, Lee Rosen, D Ross Camidge, Rui-Ru Ji, Andrea Stacey

Get full text

115 Comprehensive spatial, transcriptomic, and genomic analysis of immunogenic biliary tract cancer by James Harding, Allison Richards, Dae Won Kim, Wungki Park, Kevin Soares, Danny Khalil, Olca Basturk, Mark Donoghue, William Jarnagin, Darren Cowzer, Ghassan Abou-Alfa, Fergus Keane, Hulya Sahin Ozkan, Vasilisa Rudneva, Bruno A Costa, Zeyneb Tarcan, Eileen M O’Reilly

Mouse characteristics that affect establishing xenografts from hepatocellular carcinoma patient biopsies in the United States by Chenhui Zou, Imane El Dika, Koen O. A. Vercauteren, Marinela Capanu, Joanne Chou, Jinru Shia, Jill Pilet, Corrine Quirk, Gadi Lalazar, Linda Andrus, Mohammad Kabbani, Amin Yaqubie, Danny Khalil, Taha Mergoub, Luis Chiriboga, Charles M. Rice, Ghassan K. Abou‐Alfa, Ype P. de Jong

Get full text

765 NG-350A, a tumor-selective anti-CD40 agonist expressing therapeutic, gemcitabine/nab-paclitaxel and ipilimumab for untreated metastatic pancreatic adenocarcinoma: cohort C of t... by Robert H Vonderheide, Andrew H Ko, Danny Khalil, Oliver Rosen, Robert A Wolff, James Francis, Samantha Bucktrout, Christopher R Cabanski, Silvia Boffo, Zev A Wainberg, Samik Upadhaya, Eileen M O’Reilly, Mark H O’Hara, George Fisher, Jamie Arnott, Ana Rosa Saez-Ibanez, Jay Campbell, Ute Dugan, Jill O’Donnell-Tormey